DR. ELIZABETH ANN HODAPP MD
Prescription History 1285648428
Ophthalmology in Miami, FL
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ELIZABETH ANN HODAPP MD, an active Ophthalmology specialist practicing in Miami, FL. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 405 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 156 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other FL PrescribersVs. FL Avg |
|---|---|---|---|
| Latanoprost | 156 | $21.25▼ below FL avg | ≈ Typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 156 Medicare prescriptions for Latanoprost, about the same volume as the typical Florida prescriber of this medication (156). Medicare paid an average of $21.25 per fill, versus $22.08 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the FL average for this medication. 329.5 30-Day Fills standardized to 30-day supplies 9,647 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 91 | $40.63 | ≈ Typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 91 Medicare prescriptions for Dorzolamide-Timolol, about 86% of the volume of the typical Florida prescriber of this medication (106). Medicare paid an average of $40.63 per fill, versus $31.06 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 192.2 30-Day Fills standardized to 30-day supplies 5,742 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 44 | $19.84▼ below FL avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 44 Medicare prescriptions for Timolol Maleate, about 2.2 times the volume of the typical Florida prescriber of this medication (20). Medicare paid an average of $19.84 per fill, versus $444.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the FL average for this medication. 116.8 30-Day Fills standardized to 30-day supplies 3,492 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 40 | $14.71▼ below FL avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 40 Medicare prescriptions for Brimonidine Tartrate, about half the volume of the typical Florida prescriber of this medication (80). Medicare paid an average of $14.71 per fill, versus $34.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the FL average for this medication. 78.8 30-Day Fills standardized to 30-day supplies 2,314 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 26 | $455.83 | ▼ Less than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 26 Medicare prescriptions for Rhopressa, about a third of the volume of the typical Florida prescriber of this medication (67). Medicare paid an average of $455.83 per fill, versus $455.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34.8 30-Day Fills standardized to 30-day supplies 1,000 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 23 | $480.44 | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 23 Medicare prescriptions for Lumigan, about a third of the volume of the typical Florida prescriber of this medication (81). Medicare paid an average of $480.44 per fill, versus $395.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43.8 30-Day Fills standardized to 30-day supplies 1,301 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 14 | $277.53 | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 14 Medicare prescriptions for Simbrinza, about half the volume of the typical Florida prescriber of this medication (29). Medicare paid an average of $277.53 per fill, versus $257.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20.3 30-Day Fills standardized to 30-day supplies 555 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 11 | $35.72 | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 11 Medicare prescriptions for Dorzolamide Hcl, about 18% of the volume of the typical Florida prescriber of this medication (60). Medicare paid an average of $35.72 per fill, versus $28.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31.5 30-Day Fills standardized to 30-day supplies 945 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. ELIZABETH ANN HODAPP MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Miami, FL practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among FL prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
